These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 9092854)
1. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854 [TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853 [TBL] [Abstract][Full Text] [Related]
3. Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system. Amar AP; Zlokovic BV; Apuzzo ML Neurosurgery; 2003 Feb; 52(2):402-12; discussion 412-3. PubMed ID: 12535371 [TBL] [Abstract][Full Text] [Related]
4. Liposomal and viral vectors for gene therapy of the central nervous system. de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560 [TBL] [Abstract][Full Text] [Related]
5. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors. Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453 [TBL] [Abstract][Full Text] [Related]
6. Crossing the blood-brain-barrier with viral vectors. Fu H; McCarty DM Curr Opin Virol; 2016 Dec; 21():87-92. PubMed ID: 27591676 [TBL] [Abstract][Full Text] [Related]
7. Vector delivery methods and targeting strategies for gene therapy of brain tumors. Rainov NG; Kramm CM Curr Gene Ther; 2001 Nov; 1(4):367-83. PubMed ID: 12109063 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9. Saraiva J; Nobre RJ; Pereira de Almeida L J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390 [TBL] [Abstract][Full Text] [Related]
9. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419 [TBL] [Abstract][Full Text] [Related]
10. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice. Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804 [TBL] [Abstract][Full Text] [Related]
11. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier. Stanimirovic DB; Sandhu JK; Costain WJ BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341 [TBL] [Abstract][Full Text] [Related]
12. Current status of non-viral gene therapy for CNS disorders. Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310 [TBL] [Abstract][Full Text] [Related]
13. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
14. Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. Hermens WT; Giger RJ; Holtmaat AJ; Dijkhuizen PA; Houweling DA; Verhaagen J J Neurosci Methods; 1997 Jan; 71(1):85-98. PubMed ID: 9125378 [TBL] [Abstract][Full Text] [Related]
15. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors. Puhl DL; D'Amato AR; Gilbert RJ Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859 [TBL] [Abstract][Full Text] [Related]
16. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells. Oshiro EM; Viola JJ; Oldfield EH; Walbridge S; Bacher J; Frank JA; Blaese RM; Ram Z Cancer Gene Ther; 1995 Jun; 2(2):87-95. PubMed ID: 7621261 [TBL] [Abstract][Full Text] [Related]